| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/28/2007 | CN1921845A Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation |
| 02/28/2007 | CN1921841A Amines and amides for the treatment of diseases |
| 02/28/2007 | CN1919857A Preparation method and application of water-soluble mangiferin monosodium salt |
| 02/28/2007 | CN1919856A Caulis trachelospermi total lignans extractive, extraction method and medicine use of the extractive and active constituent thereof |
| 02/28/2007 | CN1919853A Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 02/28/2007 | CN1919848A bilobalide K and complex thereof, preparation method and use for the same |
| 02/28/2007 | CN1919334A Medicinal foodstuff for treating menorrhalgia of cold and qi stagnation type and its preparing process |
| 02/28/2007 | CN1919324A Medicinal liquor for bone health |
| 02/28/2007 | CN1919323A Acupoint application medicine for treating post partum fever and its preparing process |
| 02/28/2007 | CN1919282A Decoction medicine for treating menorrhalgia of liver energy depression and phlegm stagnation type and its preparing process |
| 02/28/2007 | CN1919281A Foot soaking medicine for treating menorrhalgia of liver energy depression type and its preparing process |
| 02/28/2007 | CN1919279A Plaster with wind and cold dispelling, toxin removing and clots absorbing function, and its preparing process |
| 02/28/2007 | CN1919278A Blood activating oil and its preparation method |
| 02/28/2007 | CN1919270A Composition, exract, and pharmaceutical use thereof |
| 02/28/2007 | CN1919267A Decoction medicine for treating menorrhalgia of cold - stagnation and blood - stasis type and its preparing process |
| 02/28/2007 | CN1919231A Numbness solution |
| 02/28/2007 | CN1919227A Decoction medicine for treating ordinary menorrhalgia and its preparing process |
| 02/28/2007 | CN1919222A Process for preparing notoginsen triterpenes |
| 02/28/2007 | CN1919217A Capsule made of ant extract, spirulina platensis dry powder and chinese caterpillar fungus extract |
| 02/28/2007 | CN1919198A Piroxicam medicinal preparation and preparing method thereof |
| 02/28/2007 | CN1919189A Ibuprofen granule and preparing method thereof |
| 02/28/2007 | CN1919188A Ibuprofen medicinal preparation and preparing method thereof |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301987C 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 02/28/2007 | CN1301981C Medicinal composition containing 1,3-thiazine derivative |
| 02/28/2007 | CN1301980C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CN1301709C Skin plaster containing aceclofenac |
| 02/27/2007 | US7183440 Pharmaceutically useful compounds |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183275 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 02/27/2007 | US7183274 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 02/27/2007 | US7183264 Such as ethyl-1-(9-((4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxy-methyl)oxolan-2-yl)-6 -aminopurin-2-yl)pyrazole-4-carboxylate; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7182963 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 02/27/2007 | US7182199 Systems, methods and apparatuses for manufacturing dosage forms |
| 02/27/2007 | CA2425849C Angiostatic steroids |
| 02/26/2007 | CA2557377A1 Mucosal delivery tablet |
| 02/26/2007 | CA2517313A1 Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist |
| 02/22/2007 | WO2007021803A1 Compounds for the treatment of inflammatory disorders |
| 02/22/2007 | WO2007021710A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 02/22/2007 | WO2007020917A1 Agent for enhancing and prolonging utrophin production and processed food comprising the same |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020403A1 Azapeptides for treating hyperalgesic pain conditions |
| 02/22/2007 | WO2006127379A3 Par2-modulating compounds and their use |
| 02/22/2007 | WO2006112744A3 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 02/22/2007 | WO2006105214A3 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| 02/22/2007 | WO2006081431A3 Compounds for treating inflammatory and demyelinating diseases |
| 02/22/2007 | WO2006062981A3 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043084 1,2-Diarylimidazoles useful as inhibitors of cox |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043073 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use |
| 02/22/2007 | US20070043013 1,3 Disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 02/22/2007 | US20070042978 Nf-hev compositions and methods of use |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042941 Galectin 9-inducing factors |
| 02/22/2007 | US20070042439 Porphyrin compound containing biotinyl group and use thereof |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042006 Stable carprofen composition |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | DE10101522B4 Neue pharmazeutische Verwendung einer Kombination aus Ascorbat und mindestens einem Fibrinolysehemmer New pharmaceutical use a combination of ascorbate and at least one Fibrinolysehemmer |
| 02/22/2007 | CA2818921A1 Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events |
| 02/22/2007 | CA2618679A1 Compounds for the treatment of inflammatory disorders |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618614A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1754492A1 Novel drug discovery target and medicine acting on the same |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1753764A1 Pyrrolopyridine derivatives |
| 02/21/2007 | EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
| 02/21/2007 | EP1581517B1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1390474B1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/21/2007 | EP1358156B1 Benz(g) indoles and their use as spla2 inhibitors |
| 02/21/2007 | EP1356811B1 Combination of three substances for the prevention or treatment of arthritis |